A three-dimensional collagen scaffold cell culture system for screening anti-glioma therapeutics
- PMID: 27486877
- PMCID: PMC5302961
- DOI: 10.18632/oncotarget.10885
A three-dimensional collagen scaffold cell culture system for screening anti-glioma therapeutics
Abstract
Three-dimensional (3D) culture, which can simulate in vivo microenvironments, has been increasingly used to study tumor cell biology. Since most preclinical anti-glioma drug tests still rely on conventional 2D cell culture, we established a collagen scaffold for 3D glioma cell culture. Glioma cells cultured on these 3D scaffolds showed greater degree of dedifferentiation and quiescence than cells in 2D culture. 3D-cultured cells also exhibited enhanced resistance to chemotherapeutic alkylating agents, with a much higher proportion of glioma stem cells and upregulation of O6-methylguanine DNA methyltransferase (MGMT). Importantly, tumor cells in 3D culture showed chemotherapy resistance patterns similar to those observed in glioma patients. Our results suggest that 3D collagen scaffolds are promising in vitro research platforms for screening new anti-glioma therapeutics.
Keywords: MGMT; chemosensitivity; collagen scaffold; glioma stem cells; three-dimensional culture.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Shoemaker RH. The NCI60 human tumour cell line anticancer drug screen. Nature Reviews Cancer. 2006;6:813–823. - PubMed
-
- Birgersdotter A, Sandberg R, Ernberg I. Gene expression perturbation in vitro - A growing case for three-dimensional (3D) culture systems. Seminars in Cancer Biology. 2005;15:405–412. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
